![](/img/cover-not-exists.png)
The benefits and risks of alemtuzumab in multiple sclerosis
Ontaneda, Daniel, Cohen, Jeffrey AVolume:
9
Language:
english
Journal:
Expert Review of Clinical Immunology
DOI:
10.1586/eci.13.1
Date:
March, 2013
File:
PDF, 690 KB
english, 2013